Edwards Lifesciences revenue and financials
$86.48Change from previous close: −0.86%Absolute change: −$0.75
In the fiscal year ended December 2025, Edwards Lifesciences reported revenue of $6.07B (+11.55% year over year). Net income was $1.07B, a net margin of 17.7%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +11.55%
- 2025 vs 2024
- Net income growth
- −74.28%
- 2025 vs 2024
- Net margin
- 17.7%
- 2024: 76.7%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 13,867 | 13,321 | 13,697 | 13,272 | 13,489 | 13,022 | 13,055 | 12,971 | 10,099 | 9,736 | 9,363 | 9,371 |
| Current assets | 6,819 | 6,229 | 6,739 | 6,359 | 6,577 | 6,213 | 6,285 | 6,728 | 4,516 | 4,171 | 4,036 | 4,068 |
| Cash and equivalents | 2,907 | 2,446 | 2,938 | 2,686 | 3,273 | 3,141 | 3,045 | 3,676 | 1,645 | 1,225 | 1,132 | 1,410 |
| Short-term investments | 1,346 | 1,226 | 1,288 | 1,156 | 789 | 758 | 931 | 770 | 345 | 473 | 501 | 454 |
| Receivables | 956 | 973 | 912 | 893 | 903 | 752 | 727 | 812 | 834 | 877 | 828 | 802 |
| Inventory | 1,131 | 1,119 | 1,126 | 1,141 | 1,142 | 1,114 | 1,087 | 1,104 | 1,025 | 1,207 | 904 | 1,032 |
| Net property, plant and equipment | 1,942 | 1,922 | 1,915 | 1,840 | 1,826 | 1,795 | 1,784 | 1,780 | 1,733 | 1,866 | 1,675 | 1,772 |
| Goodwill | 1,951 | 1,820 | 1,769 | 1,769 | 1,777 | 1,779 | 1,777 | 1,605 | 1,151 | 1,253 | 1,145 | 1,297 |
| Other intangible assets | 1,383 | 1,228 | 1,128 | 1,131 | 1,173 | 1,175 | 1,177 | 956 | 417 | 447 | 399 | 430 |
| Long-term investments | 244 | 286 | 279 | 275 | 299 | 278 | 308 | 320 | 353 | 456 | 584 | 705 |
| Current liabilities | 1,508 | 1,409 | 1,814 | 1,588 | 1,405 | 1,395 | 1,505 | 1,944 | 1,217 | 1,111 | 1,195 | 1,239 |
| Accounts payable | 211 | 181 | 228 | 165 | 162 | 172 | 197 | 173 | 186 | 212 | 187 | 191 |
| Long-term debt | 599 | 599 | 598 | 598 | 598 | 598 | 598 | 598 | 597 | 597 | 597 | 597 |
| Total debt | — | 703 | 705 | 700 | 703 | 699 | — | — | — | — | — | — |
| Total liabilities | 3,142 | 2,994 | 3,360 | 3,067 | 2,882 | 2,831 | 2,992 | 3,360 | 2,595 | 2,550 | 2,644 | 2,644 |
| Total equity (incl. minority) | 10,725 | 10,328 | 10,338 | 10,205 | 10,607 | 10,192 | 10,063 | 9,611 | 7,505 | 7,186 | 6,719 | 6,727 |
| Retained earnings | 14,863 | 14,621 | 14,241 | 14,149 | 13,858 | 13,525 | 13,167 | 12,781 | 9,711 | 9,344 | 8,992 | 8,623 |
| Minority interest | 107 | — | 0.0 | 0.0 | 61.2 | 62.9 | 64.5 | 65.8 | 67.2 | 68.5 | 69.4 | 69.6 |